EQL Pharma Investor Relations

List change 2024

Nasdaq Stockholm’s listing committee announced on 12 June 2024 that EQL Pharma AB (“EQL”) meets the applicable listing requirements and has approved the application for admission to trading of the company’s shares on Nasdaq Stockholm Main Market. The first day of trading on Nasdaq Stockholm is 4 July 2024. Due to the listing, EQL will be de-listed from Spotlight Stock Market and the last day of trading on Spotlight Stock Market is 3 July 2024.

Below is a summary of the material published regarding the list change and the admission to trading of the shares in EQL on Nasdaq Stockholm.